Answers are grounded in this paper and cite their sources.
A survey carried out among first year pharmacy students on their knowledge and opinions regarding the uses of non-FDA approved use of selected psychotropic drugs, namely duloxetine, escitalopram and quetiapine, revealed mixed results. Based on a set of five knowledge-based questions, an average of 39.5% of the survey participants scored correct answers on duloxetine. For escitalopram, the average correct response rate was 47.2%, and 32.2% for quetiapine. The highest correct response rate on a single question was 89.5% for duloxetine, 87.2% on two of the questions for escitalopram, and 77.1% for quetiapine. Comparison of each of the highest correct response to each of the responses within each drug showed significant differences (p< 0.05). Conflicting opinions of survey participants were discerned regarding the off-label uses of duloxetine, with 65.8% expressing it should not be approved for urinary incontinence, and yet they are evenly divided (50% each) in their opinion on the use of non-approved drugs in general. More than 50% of the respondents held the opinion that escitalopram should not be used off-label for social phobia, while less than 41% were aware of its use for such non-approved indication. About 60% of respondents within the quetiapine survey group thought the drug should not be used for generalized anxiety disorder, which is in concordance with the low 36%-40% who believe it should be promoted for non-approved uses. Due to the small sample size of survey participants (n =37-39), the results of this survey cannot be generalized to first-year pharmacy students in other colleges of pharmacy.
No takes yet. Share an insight, caveat, or question.
Hailemeskel et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: